TLR9 activation is defective in common variable immune deficiency

Charlotte Cunningham-Rundles1, Lin Radigan, Adina K Knight

  • 1Department of Medicine and the Immunobiology Center, Mount Sinai Medical Center, New York, NY 10029, USA. Charlotte.Cunningham-Rundles@MSSM.edu

Insights

Common variable immune deficiency (CVID) involves impaired B cell responses due to Toll-like receptor 9 (TLR9) defects. These defects hinder innate immune activation by CpG-DNA, affecting B cell function and plasmacytoid dendritic cell responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Common variable immune deficiency (CVID) is a primary immune disorder marked by low immunoglobulin levels and impaired B cell function.
  • Genetic underpinnings for most CVID cases remain elusive, despite known defects in T, B, and dendritic cells.

Purpose of the Study:

  • To investigate the role of Toll-like receptor 9 (TLR9) in B cell and plasmacytoid dendritic cell activation in CVID patients.
  • To identify potential molecular defects in TLR9 signaling pathways contributing to CVID pathogenesis.

Main Methods:

  • Analysis of B cell and plasmacytoid dendritic cell activation in response to CpG-DNA, a TLR9 ligand.
  • Assessment of cell surface marker expression (e.g., CD86), cytokine production (IL-6, IL-10, IFN-alpha), and TLR9 expression (protein and mRNA) in CVID and healthy controls.
  • Sequencing of TLR9 gene to identify mutations or polymorphisms.

Main Results:

  • CVID B cells exhibited defective upregulation of CD86 and impaired production of IL-6 and IL-10 upon CpG-DNA stimulation.
  • Reduced expression of TLR9 protein and mRNA was observed in CVID B cells.
  • CpG-DNA-activated CVID plasmacytoid dendritic cells produced lower levels of IFN-alpha, despite normal intracellular TLR9 levels.
  • No mutations or polymorphisms in the TLR9 gene were identified in CVID patients.

Conclusions:

  • Broad defects in TLR9 activation pathways are present in CVID, impacting both B cells and plasmacytoid dendritic cells.
  • These TLR9 defects likely contribute to impaired innate immune responses initiated by CpG-DNA, leading to compromised B cell function and potentially altered dendritic cell activity in CVID.
  • The identified TLR9 activation defects offer potential therapeutic targets for managing CVID, independent of specific genetic mutations.

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...